Hernia Repair Device Market Size, Growth and Forecast 2032

Market Overview

Global Hernia Repair Device Market size was valued at USD 3,991.3 million in 2018 to USD 5,279.3 million in 2024 and is anticipated to reach USD 8,131.1 million by 2032, at a CAGR of 5.61% during the forecast period.

The Global Hernia Repair Device Market is shaped by the strong presence of leading companies such as Medtronic, Johnson & Johnson Services, BD (Becton, Dickinson and Company), W. L. Gore & Associates, B. Braun SE, Baxter International Inc., Cook Medical, Herniamesh S.r.l., and LifeCell Corporation. These players maintain competitive advantage through extensive product portfolios, technological innovation, and wide distribution networks. Market leaders emphasize the development of advanced meshes, absorbable fixation devices, and minimally invasive solutions to address rising surgical demand and improve patient outcomes. Regionally, North America dominated the market with a 33.5% share in 2024, driven by strong healthcare infrastructure, favorable reimbursement systems, and widespread adoption of robotic-assisted and laparoscopic procedures. This leadership reflects the region’s early adoption of innovative technologies and the presence of globally established manufacturers.

Market Insights

• The Global Hernia Repair Device Market grew from USD 3,991.3 million in 2018 to USD 5,279.3 million in 2024, with projections to reach USD 8,131.1 million by 2032.
• Hernia mesh dominated with 62% share in 2024, led by synthetic mesh at 48% due to cost-effectiveness and durability, while biologic mesh gained 14% in complex repairs.
• By type, inguinal hernia accounted for 41% share in 2024, followed by umbilical hernia at 22%, incisional at 18%, femoral at 11%, and others at 8%.
• North America led with 33.5% share in 2024, supported by advanced healthcare infrastructure, favorable reimbursement, and strong presence of global players like Medtronic and Johnson & Johnson.
• Asia Pacific showed the fastest growth with 23.6% share in 2024, driven by rising healthcare investments, growing surgical capacity, and strong demand in China, India, and Southeast Asia.

Market Segment Insights

By Product

The hernia mesh segment dominated the global market in 2024 with a 62% share, reflecting its widespread adoption in surgical procedures. Within this category, synthetic mesh accounted for the largest portion, holding 48% share, supported by its durability, cost-effectiveness, and high success rates in reducing recurrence. Biologic mesh, with an estimated 14% share, is gaining traction in complex and contaminated cases due to better tissue integration and reduced infection risks. Hernia fixation devices represented 38% share, where sutures led with 20% share, followed by tack applicators at 10%, glue applicators at 5%, and others at 3%, driven by surgeon preference and procedure type.

• For instance, Becton Dickinson’s (BD) SurgiMend® biologic mesh, derived from acellular dermal matrix, has documented use in contaminated hernia repairs where synthetic meshes are contraindicated.

By Type

The inguinal hernia segment held the dominant position in 2024 with a 41% market share, driven by its high global prevalence, particularly in men, and the widespread use of meshes for repair. The umbilical hernia segment accounted for 22% share, supported by rising obesity rates and higher incidence among infants and women. The incisional hernia segment captured 18% share, largely influenced by complications from previous abdominal surgeries. Femoral hernia repairs represented 11% share, with higher adoption in women due to anatomical predispositions. The remaining 8% share was contributed by other hernia types, including rare abdominal wall hernias, where specialized meshes and fixation devices are increasingly used.

• For instance, Medtronic’s ProGrip™ self-gripping mesh is widely adopted in inguinal hernia surgeries due to its fixation-free design, which reduces operating time.

Market Overview

Key Growth Drivers

Rising Prevalence of Hernia Cases

The global hernia repair device market grows strongly due to rising hernia prevalence worldwide. Factors such as aging populations, obesity, and sedentary lifestyles increase the risk of abdominal wall weaknesses. Inguinal and incisional hernias remain highly common, creating consistent demand for surgical interventions. Healthcare providers prefer advanced meshes and fixation devices to improve outcomes and reduce recurrence rates. Growing patient awareness, combined with higher diagnosis rates, further fuels procedure volumes. This increasing disease burden continues to drive adoption of innovative hernia repair devices globally.

• For instance, W.L. Gore & Associates introduced the Gore® Synecor Preperitoneal Biomaterial in 2017, combining permanent and bioabsorbable layers, enabling surgeons to customize repair approaches and enhance patient recovery in complex hernia cases.

Technological Advancements in Surgical Procedures

Technological progress in minimally invasive and robotic-assisted surgeries drives the hernia repair device market. Surgeons increasingly adopt laparoscopic procedures that reduce hospital stays, lower infection risks, and ensure quicker recovery. Companies invest in next-generation meshes with biocompatible materials and fixation systems that improve patient safety. Robotics adds precision in complex cases, enhancing surgical efficiency and reducing complications. Continuous improvements in device design, absorbable materials, and tailored mesh solutions strengthen market growth by meeting evolving clinical demands and improving long-term patient outcomes.

• For instance, Medtronic’s Symbotex™ Composite Mesh incorporates a resorbable collagen barrier that minimizes tissue attachment and enhances tissue integration.

Expanding Healthcare Infrastructure and Expenditure

Rising healthcare investments globally strengthen the adoption of advanced hernia repair devices. Emerging economies, including India, China, and Brazil, expand healthcare facilities and surgical capacities. Government initiatives to modernize healthcare and improve surgical access encourage adoption of minimally invasive treatments. Insurance coverage and reimbursement support in developed markets further boost device uptake. Hospitals and specialty clinics increasingly prefer advanced meshes and fixation devices to reduce complications. Growing focus on cost-effective and efficient surgical care enhances device penetration, supporting sustained market expansion.

Key Trends & Opportunities

Shift Toward Biologic and Absorbable Meshes

The global hernia repair device market shows a clear shift toward biologic and absorbable meshes. Surgeons and patients prefer materials that integrate with body tissues and reduce risks of infection or rejection. Biologic meshes offer advantages in complex and contaminated hernia repairs, gaining wide acceptance in developed markets. Research efforts focus on combining strength with natural tissue compatibility. This trend opens opportunities for manufacturers to expand portfolios with innovative, patient-centric solutions, positioning biologic and absorbable meshes as key growth segments.

• For instance, Integra LifeSciences’ SurgiMend® a biologic mesh derived from fetal bovine dermis has gained adoption in the U.S. for complex abdominal wall reconstructions where infection risk is high.

Growth in Outpatient and Ambulatory Surgical Centers

Ambulatory surgical centers (ASCs) are playing a bigger role in hernia repair procedures. Patients seek cost-effective, minimally invasive treatments with faster recovery, making ASCs an attractive choice. Hospitals also face pressure to optimize resources, pushing simpler procedures toward outpatient facilities. Device makers benefit from developing specialized products suited for quick, minimally invasive surgeries. The growing preference for ASCs provides opportunities to expand device penetration, particularly in regions with strong insurance coverage and cost-focused healthcare systems. This trend accelerates adoption of advanced hernia repair solutions.

• For instance, Medtronic has reported growing demand for its ProGrip™ Laparoscopic Self-Fixating Mesh, highlighting its suitability for quicker hernia repair procedures conducted in ASC settings.

Key Challenges

Risk of Postoperative Complications and Recurrence

Despite advancements, postoperative complications and hernia recurrence remain major challenges in the global hernia repair device market. Issues such as chronic pain, mesh rejection, and infection impact patient outcomes. Recurrence rates vary depending on procedure type and device used, leading to hesitation among patients and surgeons. Negative experiences can discourage adoption of certain meshes or fixation systems. Manufacturers must focus on improving product safety, biocompatibility, and long-term performance to address these risks and maintain trust among healthcare professionals and patients.

High Cost of Advanced Devices and Procedures

The high cost of advanced hernia repair devices and minimally invasive surgeries limits adoption, particularly in developing economies. Biologic meshes and robotic-assisted systems involve significant expense, restricting access for low- and middle-income populations. Limited reimbursement policies in certain regions further increase financial barriers for patients. Hospitals in cost-sensitive markets often rely on conventional methods, slowing uptake of innovative devices. Addressing affordability and demonstrating cost-effectiveness through clinical outcomes will be crucial for wider penetration in price-sensitive healthcare environments.

Shortage of Skilled Surgeons for Minimally Invasive Procedures

The adoption of advanced hernia repair devices often depends on the availability of skilled surgeons. Many regions, especially in emerging markets, face shortages of professionals trained in laparoscopic and robotic-assisted techniques. Limited training infrastructure and steep learning curves slow the spread of these advanced methods. This challenge restricts device demand, particularly for high-tech meshes and fixation systems designed for minimally invasive surgeries. Expanding surgical training programs and partnerships with hospitals will be critical for manufacturers to overcome workforce limitations and unlock growth.

Regional Analysis

North America

North America accounted for 33.5% of the global hernia repair device market in 2024, supported by strong healthcare infrastructure and high surgical procedure volumes. The market grew from USD 1,325.50 million in 2018 to USD 1,703.25 million in 2024 and is projected to reach USD 2,520.63 million by 2032, registering a CAGR of 5.1%. Widespread adoption of minimally invasive and robotic-assisted surgeries drives growth, along with favorable reimbursement policies. The U.S. dominates the region due to advanced surgical capabilities, strong demand for biologic meshes, and continuous innovation by key players such as Medtronic and Johnson & Johnson.

Europe

Europe represented 25.7% of the global market in 2024, fueled by growing demand for biologic and synthetic meshes. The market expanded from USD 986.24 million in 2018 to USD 1,308.13 million in 2024 and is anticipated to reach USD 2,022.20 million by 2032 at a CAGR of 5.7%. Countries such as Germany, France, and the UK lead adoption due to advanced healthcare systems and strong awareness of minimally invasive procedures. Supportive regulatory frameworks and emphasis on cost-effective, safe hernia repair methods further enhance regional growth. Local manufacturers also contribute through specialized fixation devices and mesh innovations.

Asia Pacific

Asia Pacific held 23.6% of the global market in 2024, showing strong growth potential. The market rose from USD 873.69 million in 2018 to USD 1,199.76 million in 2024 and is forecast to reach USD 1,938.45 million by 2032, advancing at the highest regional CAGR of 6.2%. Rapid healthcare infrastructure development in China, India, and Southeast Asia, coupled with rising obesity and aging populations, fuels demand. Growing access to minimally invasive surgeries and increasing government healthcare spending drive expansion. Multinational companies are actively entering this market through partnerships and training programs to address the shortage of skilled surgeons.

Latin America

Latin America contributed 10.7% to the global market in 2024, driven by increasing awareness of surgical treatments and expanding healthcare access. The market grew from USD 407.51 million in 2018 to USD 545.80 million in 2024 and is projected to reach USD 854.57 million by 2032, reflecting a CAGR of 5.8%. Brazil dominates regional adoption due to its large patient pool and improving surgical infrastructure. Mexico and Argentina are also emerging markets where growing private healthcare and government initiatives are driving demand. However, cost constraints in rural areas continue to limit widespread adoption of advanced hernia repair devices.

Middle East

The Middle East captured 7.9% of the global market in 2024, reflecting robust expansion in GCC countries and Israel. Market revenues rose from USD 292.16 million in 2018 to USD 402.06 million in 2024 and are forecast to reach USD 651.30 million by 2032 at a CAGR of 6.3%. Increasing adoption of minimally invasive surgeries, rising investments in healthcare infrastructure, and government-led modernization initiatives fuel demand. GCC countries drive much of this growth with advanced hospitals and rising surgical capacities. Strong preference for technologically advanced fixation devices and premium meshes positions the region as a lucrative emerging market.

Africa

Africa accounted for the smallest share at 2.4% of the global hernia repair device market in 2024. The market expanded from USD 106.17 million in 2018 to USD 120.29 million in 2024 and is projected to reach USD 143.92 million by 2032, registering the lowest regional CAGR of 2.3%. Growth is hindered by limited access to advanced healthcare, low awareness, and affordability challenges. However, countries such as South Africa and Egypt lead adoption due to better healthcare infrastructure and growing medical tourism. Efforts by NGOs and government programs to expand surgical care access are expected to provide modest growth opportunities.

Market Segmentations:

By Product

• Hernia Mesh
• Biologic Mesh
• Synthetic Mesh
• Hernia Fixation Devices
• Sutures
• Tack Applicators
• Glue Applicators
• Others

By Type

• Inguinal Hernia
• Umbilical Hernia
• Incisional Hernia
• Femoral Hernia
• Others

By Region

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• France
• Germany
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America

Middle East

• GCC Countries
• Israel
• Turkey
• Rest of Middle East

Africa

• South Africa
• Egypt
• Rest of Africa

Competitive Landscape

The global hernia repair device market is moderately consolidated, with leading multinational companies holding significant market share through strong product portfolios and global distribution networks. Key players such as Medtronic, Johnson & Johnson Services, BD, W. L. Gore & Associates, and B. Braun SE dominate the space with advanced meshes, fixation devices, and minimally invasive solutions. These companies emphasize product innovation, including biologic and absorbable meshes designed to improve patient safety and reduce recurrence rates. Regional players like Herniamesh S.r.l. and LifeCell Corporation also strengthen competition by offering cost-effective and specialized products. Strategic initiatives, including mergers, acquisitions, and collaborations, expand geographic reach and enhance technology adoption. For instance, partnerships with hospitals and training programs help manufacturers promote minimally invasive and robotic-assisted procedures. Continuous investment in R&D, coupled with efforts to address affordability and access in emerging markets, shapes the competitive dynamics of this growing global industry.

Key Players

• Medtronic
• Johnson & Johnson Services, Inc.
• BD (Becton, Dickinson and Company)
• L. Gore & Associates, Inc.
• Braun SE
• Baxter International Inc.
• Cook Medical
• Herniamesh S.r.l.
• LifeCell Corporation
• Other Key Players

Recent Developments

• In July 2025, Medtronic secured CE Mark approval for LigaSure™ RAS integration on the Hugo system and showcased telesurgery capabilities at the SRS 2025 meeting.
• In April 2025, BD (Becton, Dickinson and Company) received FDA 510(k) clearance and launched Phasix™ ST Umbilical Hernia Patch, the first fully absorbable hernia patch designed specifically for umbilical hernias.
• In 2024, Medtronic introduced a next-generation polypropylene mesh that cuts flexibility and inflammation risk.

Report Coverage

The research report offers an in-depth analysis based on Type, Product and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. Demand for minimally invasive and robotic-assisted hernia repair procedures will continue to rise.
2. Adoption of biologic and absorbable meshes will expand in complex and contaminated cases.
3. Manufacturers will focus on developing lighter, more biocompatible, and infection-resistant mesh materials.
4. Training programs for surgeons in laparoscopic and robotic techniques will increase globally.
5. Emerging economies will see stronger adoption as healthcare infrastructure and awareness improve.
6. Outpatient and ambulatory surgical centers will play a larger role in hernia repair treatments.
7. Strategic mergers and acquisitions will strengthen company portfolios and regional presence.
8. Cost-effective product innovations will target affordability challenges in low- and middle-income countries.
9. Regulatory focus on patient safety and long-term outcomes will drive product improvements.
10. Digital tools and data-driven platforms will support preoperative planning and postoperative monitoring.

Rising Prevalence of Hernia Cases

Increasing rates of obesity, aging populations, and sedentary lifestyles are leading to a higher incidence of hernias globally, which in turn drives demand for hernia repair devices and surgical interventions.

Technological Advancements in Surgical Procedures

The adoption of minimally invasive and robotic-assisted surgeries is accelerating, as these techniques reduce recovery times and complications, prompting hospitals and surgeons to invest in advanced hernia repair devices such as biocompatible meshes and absorbable fixation systems.

Shift Toward Biologic and Absorbable Meshes

Surgeons and patients are increasingly favoring biologic and absorbable meshes for their improved tissue integration and lower infection risks, especially in complex or contaminated cases, creating new growth opportunities for manufacturers.

Expanding Healthcare Infrastructure and Expenditure

Emerging economies are investing heavily in healthcare infrastructure and surgical capacity, while developed markets benefit from favorable reimbursement and insurance coverage, collectively boosting the adoption of advanced hernia repair devices.

Growth in Outpatient and Ambulatory Surgical Centers

The trend toward performing hernia repairs in ambulatory surgical centers and outpatient settings is increasing, as these facilities offer cost-effective, minimally invasive procedures with faster patient recovery, thereby expanding the market for specialized hernia repair devices.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.